TB-500 (Thymosin Beta 4) 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of TB-500 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, spectrometric and mass spectrometry techniques. Batch: GF-TB50010-B241 Key analytical results include:

• Assay Content: 12.85 mg
• Identification – Retention Time: 0.993
• Identification – FTIR Spectrum: 997
• Molecular Ion Mass Identification: 4962 Da
• Purity: 99.7 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures provide confirmation of identity, purity, batch consistency and laboratory-grade research quality.

Product Overview

TB-500 is a synthetic peptide research compound based on Thymosin Beta 4, widely studied in controlled laboratory environments focused on cellular signalling pathways, peptide-mediated biological processes and tissue-related research models. The compound has become one of the most frequently referenced peptides within experimental research involving cell migration, molecular communication pathways and peptide-regulated biological mechanisms. This preparation contains 10 mg of high-purity lyophilized peptide supplied in a sealed research vial. Lyophilization helps preserve compound stability and allows researchers to reconstitute the peptide for controlled in vitro experimentation. Due to its defined molecular structure and extensive scientific interest, TB-500 remains a frequently utilised compound in modern peptide research.

Peptide Overview

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta 4 and is commonly studied in laboratory settings for its interaction with cellular signalling systems and regulatory pathways. Within experimental models, researchers frequently investigate TB-500 in relation to peptide-mediated communication networks and molecular processes involved in cellular organisation. The compound has attracted significant scientific interest because of its well-characterised structure, extensive research history and broad applicability within controlled laboratory studies. TB-500 continues to be incorporated into numerous experimental models exploring cellular responses, signalling cascades and peptide-regulated biological activity.

Historical Background and Scientific Context

Scientific interest in Thymosin Beta 4 expanded significantly during the late twentieth century as researchers investigated naturally occurring peptides involved in cellular regulation and biological signalling. Subsequent advances in peptide synthesis technology enabled the development of highly purified research-grade preparations suitable for controlled laboratory experimentation. Over time, TB-500 became a frequently referenced research compound in studies examining peptide-mediated biological processes and molecular signalling mechanisms. The peptide remains an important subject of investigation within numerous academic and laboratory research settings worldwide.

Mechanistic Focus in Research

Within controlled laboratory settings, TB-500 is commonly studied in relation to peptide-mediated signalling networks and cellular regulatory mechanisms. Research investigations frequently explore the compound in experimental models examining:

• Cellular signalling pathways
• Peptide-mediated communication systems
• Molecular regulatory mechanisms
• Intracellular signalling cascades
• Cell migration research models
• Comparative peptide pathway analysis
• Peptide-receptor interaction studies

These experimental approaches allow researchers to investigate biological processes associated with peptide signalling and cellular regulation.

Research Applications

In controlled research environments, TB-500 may be utilised in experimental models designed to investigate peptide signalling systems and cellular regulatory pathways. Examples of research applications include:

• Cell signalling pathway research
• Peptide interaction studies
• Molecular pathway investigations
• Comparative peptide compound research
• Cellular communication modelling
• Biological signalling analysis
• Controlled in vitro peptide studies

These applications are conducted exclusively within laboratory environments and are intended to improve scientific understanding of peptide-mediated biological processes.

Grail Formula Quality

Every Grail Formula research compound is produced and handled according to strict quality standards designed to support reliable laboratory experimentation. Each batch undergoes comprehensive independent analytical testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity confirmation
• Molecular mass verification
• Microbial safety screening
• Endotoxin analysis
• Heavy metal screening
• Full batch traceability

Independent laboratory verification provides researchers with transparent analytical data and confidence in the consistency of the supplied research material.

When You Choose Grail Formula

When selecting Grail Formula, researchers gain access to independently verified research compounds supported by extensive analytical documentation and batch-specific testing. Our commitment to transparency includes publication of assay results, purity verification, identity confirmation, endotoxin testing, microbial screening, elemental impurity analysis and molecular mass verification. Every batch is supported by a downloadable Certificate of Analysis, providing full traceability and independent verification from Liquilabs s.r.o. Czechia.

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.7 % purity confirmed by COA
• Assay content verified at 12.85 mg
• Molecular ion mass identified at 4962 Da
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• Thymosin Beta 4 (TB-500) peptide research compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.